Intraperitoneal hyperthermic chemotherapy in gastric cancer: Rationale for a new approach

Federico Bozzetti, Maurizio Vaglini, Marcello Deraco

Research output: Contribution to journalArticle

Abstract

There is preliminary evidence from experience in the treatment of various abdominal malignancies that intraperitoneal chemotherapy alone or combined with hyperthermia may attain a role in the therapeutic strategy. This paper considers the rationale for such an approach, as well as its current results and potential indications in patients with gastric cancer. The literature is critically reviewed, with special emphasis on specific topics such as patterns of tumor spread, mechanisms of local recurrence, the rationale for intraperitoneal chemotherapy and intraperitoneal hyperthermic chemotherapy, toxicity, and results from non-controlled as well as randomized clinical trials in patients with gastric cancer. There is some evidence that intraperitoneal hyperthermic chemotherapy has a favorable effect on clinical outcome in patients with limited peritoneal carcinomatosis or malignant ascitis and in those at risk of future peritoneal spread, such as patients with pT3-pT4 cancers or with positive cytology of the peritoneal fluid. Hyperthermic chemotherapy should be considered a promising approach in limited or impending peritoneal carcinomatosis, and should be included in the multidisciplinary approach to the treatment of locally advanced gastric cancer.

Original languageEnglish
Pages (from-to)483-488
Number of pages6
JournalTumori
Volume84
Issue number4
Publication statusPublished - Jul 1998

Fingerprint

Stomach Neoplasms
Drug Therapy
Carcinoma
Neoplasms
Ascitic Fluid
Cell Biology
Fever
Therapeutics
Randomized Controlled Trials
Recurrence

Keywords

  • Gastric cancer
  • Intraperitoneal hyperthermic chemotherapy
  • Locoregional chemotherapy
  • Malignant ascitis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Intraperitoneal hyperthermic chemotherapy in gastric cancer : Rationale for a new approach. / Bozzetti, Federico; Vaglini, Maurizio; Deraco, Marcello.

In: Tumori, Vol. 84, No. 4, 07.1998, p. 483-488.

Research output: Contribution to journalArticle

Bozzetti, Federico ; Vaglini, Maurizio ; Deraco, Marcello. / Intraperitoneal hyperthermic chemotherapy in gastric cancer : Rationale for a new approach. In: Tumori. 1998 ; Vol. 84, No. 4. pp. 483-488.
@article{d6fcc4b79d1341778dc6e75a7ec25349,
title = "Intraperitoneal hyperthermic chemotherapy in gastric cancer: Rationale for a new approach",
abstract = "There is preliminary evidence from experience in the treatment of various abdominal malignancies that intraperitoneal chemotherapy alone or combined with hyperthermia may attain a role in the therapeutic strategy. This paper considers the rationale for such an approach, as well as its current results and potential indications in patients with gastric cancer. The literature is critically reviewed, with special emphasis on specific topics such as patterns of tumor spread, mechanisms of local recurrence, the rationale for intraperitoneal chemotherapy and intraperitoneal hyperthermic chemotherapy, toxicity, and results from non-controlled as well as randomized clinical trials in patients with gastric cancer. There is some evidence that intraperitoneal hyperthermic chemotherapy has a favorable effect on clinical outcome in patients with limited peritoneal carcinomatosis or malignant ascitis and in those at risk of future peritoneal spread, such as patients with pT3-pT4 cancers or with positive cytology of the peritoneal fluid. Hyperthermic chemotherapy should be considered a promising approach in limited or impending peritoneal carcinomatosis, and should be included in the multidisciplinary approach to the treatment of locally advanced gastric cancer.",
keywords = "Gastric cancer, Intraperitoneal hyperthermic chemotherapy, Locoregional chemotherapy, Malignant ascitis",
author = "Federico Bozzetti and Maurizio Vaglini and Marcello Deraco",
year = "1998",
month = "7",
language = "English",
volume = "84",
pages = "483--488",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Intraperitoneal hyperthermic chemotherapy in gastric cancer

T2 - Rationale for a new approach

AU - Bozzetti, Federico

AU - Vaglini, Maurizio

AU - Deraco, Marcello

PY - 1998/7

Y1 - 1998/7

N2 - There is preliminary evidence from experience in the treatment of various abdominal malignancies that intraperitoneal chemotherapy alone or combined with hyperthermia may attain a role in the therapeutic strategy. This paper considers the rationale for such an approach, as well as its current results and potential indications in patients with gastric cancer. The literature is critically reviewed, with special emphasis on specific topics such as patterns of tumor spread, mechanisms of local recurrence, the rationale for intraperitoneal chemotherapy and intraperitoneal hyperthermic chemotherapy, toxicity, and results from non-controlled as well as randomized clinical trials in patients with gastric cancer. There is some evidence that intraperitoneal hyperthermic chemotherapy has a favorable effect on clinical outcome in patients with limited peritoneal carcinomatosis or malignant ascitis and in those at risk of future peritoneal spread, such as patients with pT3-pT4 cancers or with positive cytology of the peritoneal fluid. Hyperthermic chemotherapy should be considered a promising approach in limited or impending peritoneal carcinomatosis, and should be included in the multidisciplinary approach to the treatment of locally advanced gastric cancer.

AB - There is preliminary evidence from experience in the treatment of various abdominal malignancies that intraperitoneal chemotherapy alone or combined with hyperthermia may attain a role in the therapeutic strategy. This paper considers the rationale for such an approach, as well as its current results and potential indications in patients with gastric cancer. The literature is critically reviewed, with special emphasis on specific topics such as patterns of tumor spread, mechanisms of local recurrence, the rationale for intraperitoneal chemotherapy and intraperitoneal hyperthermic chemotherapy, toxicity, and results from non-controlled as well as randomized clinical trials in patients with gastric cancer. There is some evidence that intraperitoneal hyperthermic chemotherapy has a favorable effect on clinical outcome in patients with limited peritoneal carcinomatosis or malignant ascitis and in those at risk of future peritoneal spread, such as patients with pT3-pT4 cancers or with positive cytology of the peritoneal fluid. Hyperthermic chemotherapy should be considered a promising approach in limited or impending peritoneal carcinomatosis, and should be included in the multidisciplinary approach to the treatment of locally advanced gastric cancer.

KW - Gastric cancer

KW - Intraperitoneal hyperthermic chemotherapy

KW - Locoregional chemotherapy

KW - Malignant ascitis

UR - http://www.scopus.com/inward/record.url?scp=0031788498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031788498&partnerID=8YFLogxK

M3 - Article

C2 - 9825001

AN - SCOPUS:0031788498

VL - 84

SP - 483

EP - 488

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 4

ER -